| Original language | English (US) |
|---|---|
| Pages (from-to) | 488-490 |
| Number of pages | 3 |
| Journal | Journal of Neurology, Neurosurgery and Psychiatry |
| Volume | 90 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1 2019 |
Keywords
- MRI
- Multiple sclerosis
- Myelin
- Myelopathy
- Neuroimmunology
ASJC Scopus subject areas
- Surgery
- Clinical Neurology
- Psychiatry and Mental health
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Glial fibrillary acidic protein IgG related myelitis : Characterisation and comparison with aquaporin-4-IgG myelitis. / Sechi, Elia; Morris, P. Pearse; Mckeon, Andrew; Pittock, Sean J.; Hinson, Shannon R.; Weinshenker, Brian G.; Aksamit, Allen J.; Krecke, Karl N.; Kaufmann, Timothy J.; Jolliffe, Evan A.; Zalewski, Nicholas L.; Zekeridou, Anastasia; Wingerchuk, Dean M.; Jitprapaikulsan, Jiraporn; Flanagan, Eoin P.
In: Journal of Neurology, Neurosurgery and Psychiatry, Vol. 90, No. 4, 01.04.2019, p. 488-490.Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - Glial fibrillary acidic protein IgG related myelitis
T2 - Characterisation and comparison with aquaporin-4-IgG myelitis
AU - Sechi, Elia
AU - Morris, P. Pearse
AU - Mckeon, Andrew
AU - Pittock, Sean J.
AU - Hinson, Shannon R.
AU - Weinshenker, Brian G.
AU - Aksamit, Allen J.
AU - Krecke, Karl N.
AU - Kaufmann, Timothy J.
AU - Jolliffe, Evan A.
AU - Zalewski, Nicholas L.
AU - Zekeridou, Anastasia
AU - Wingerchuk, Dean M.
AU - Jitprapaikulsan, Jiraporn
AU - Flanagan, Eoin P.
N1 - Funding Information: no personal fees or personal compensation for these consulting activities. All compensation for consulting activities is paid directly to Mayo Clinic. sJP has received a research grant from Alexion Pharmaceuticals for an investigator-initiated study and support from the NIH(rO1 Ns065829-01) and the Guthy Jackson Charitable Foundation for neuromyelitisoptica research. BGW receives royalties from rsr Ltd, Oxford University, Hospices Civil de Lyon and MVZ Labor PD Dr. Volkmann und Kollegen Gbr for a patent of NMO-IgG as a diagnostic test for NMO and related disorders. He serves as a member of an adjudication committee for clinical trials in NMO being conducted by MedImmune and Alexion pharmaceutical companies. He is aconsultant for Caladrius Biosciences regarding a clinical trial for NMO. Funding Information: acknowledgements We would like to acknowledge the Mayo Clinic Center for Multiple sclerosis and Autoimmune Neurology that provided support through a translational clinical fellowship grant for this study.
PY - 2019/4/1
Y1 - 2019/4/1
KW - MRI
KW - Multiple sclerosis
KW - Myelin
KW - Myelopathy
KW - Neuroimmunology
UR - http://www.scopus.com/inward/record.url?scp=85050618088&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050618088&partnerID=8YFLogxK
U2 - 10.1136/jnnp-2018-318004
DO - 10.1136/jnnp-2018-318004
M3 - Review article
C2 - 30032117
AN - SCOPUS:85050618088
VL - 90
SP - 488
EP - 490
JO - Journal of Neurology, Neurosurgery and Psychiatry
JF - Journal of Neurology, Neurosurgery and Psychiatry
SN - 0022-3050
IS - 4
ER -